EMAIL THIS PAGE TO A FRIEND

Infection and immunity

Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation.


PMID 26034214

Abstract

Escherichia coli is a major cause of life-threatening infections in patients with neutropenia, particularly those receiving chemotherapy for the treatment of cancer. In most cases, these infections originate from opportunistic strains living within the patient's gastrointestinal tract which then translocate to major organ systems. There are no animal models that faithfully recapitulate these infections, and, as such, the host or bacterial factors that govern this process remain unidentified. We present here a novel model of chemotherapy-induced bacterial translocation of E. coli. Oral gavage of BALB/c mice with a clinical isolate of extraintestinal pathogenic E. coli (ExPEC) leads to stable and long-term colonization of the murine intestine. Following the induction of neutropenia with the chemotherapeutic drug cyclophosphamide, ExPEC translocates from the intestine to the lungs, liver, spleen, and kidneys with concomitant morbidity in infected animals. Translocation can also occur in mice bearing mammary tumors, even in the absence of chemotherapy. Translocation of ExPEC is also associated with an increase of the diversity of bacterial DNA detected in the blood. This is the first report of a chemotherapy-based animal model of ExPEC translocation in cancerous mice, a system that can be readily used to identify important virulence factors for this process.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C0768
Cyclophosphamide monohydrate, bulk package
C7H15Cl2N2O2P · H2O
C7397
Cyclophosphamide monohydrate, ISOPAC®
C7H15Cl2N2O2P · H2O